Researchers at MIT and Harvard have developed CAR-NK cells, which could lead to more effective cancer treatment.

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi were awarded the 2025 Nobel Prize in Physiology or Medicine on Monday for ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing immune cells that could make “off-the-shelf” cancer medications more potent ...

Due to the small size and height of the Eva1 molecule, Eva1CAR-T cells can form more effective immune synapses—contact zones between an immune cell and its target tumor cells. The formation of robust ...

Cancer can grow slowly or appear suddenly. It happens when cells stop following normal instructions and start behaving badly. For decades, doctors focused on killing these cells using chemotherapy or ...

Borrowing a cancer cell’s disguise, scientists shielded insulin-producing cells from attack by the immune system, a breakthrough that could pave the way for targeted type 1 diabetes treatments without ...

Cancer cells have fewer heavy hydrogen atoms in their lipids as compared to healthy cells. The finding unearths a potential geochemical tool for cancer diagnosis in the future. As the daughter of a ...

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel through the blood in the circulatory system and lodge themselves in other ...